- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BMS-986171
Total 3169 results
-
Bristol-Myers SquibbCompletedVarious Advanced CancerUnited States, Australia, Brazil, Canada, France, Germany, Hong Kong, Israel, Netherlands, Norway, Poland, Russian Federation, Spain, Sweden, United Kingdom
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedRenal Cell Carcinoma | Metastatic Melanoma | Non-small Cell Lung Cancer | Metastatic Castration-resistant Prostrate CancerUnited States
-
Bristol-Myers SquibbWithdrawnNon-Small Cell Lung CancerArgentina, Peru, Germany, United States, Canada
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedGastric Cancer | Esophagogastric Junction | Cancer of the StomachUnited States, Germany, Italy, Argentina, Australia, Belgium, France, Poland, Puerto Rico, Spain, Czechia, Austria, Canada, United Kingdom, Chile, Norway, Singapore
-
National Institute of Allergy and Infectious Diseases...CompletedHIV InfectionsUnited States
-
Mansoura UniversityUnknown
-
Bristol-Myers SquibbTerminated
-
Bristol-Myers SquibbYale UniversityCompletedNon-Small Cell Lung CancerBelgium, Italy, United States, France, Germany, Netherlands, Spain, Romania
-
Hackensack Meridian HealthTerminatedAcute Myeloid Leukemia and Myelodysplastic SyndromeUnited States
-
Boston Scientific CorporationCompletedErectile Dysfunction | ImpotenceUnited States, Canada
-
JIANYANG WANGCancer Institute and Hospital, Chinese Academy of Medical SciencesRecruitingEsophageal Cancer | Thrombocytopenia | Concurrent Chemoradiotherapy | Intensity-modulated Radiation TherapyChina
-
Bristol-Myers SquibbCompletedHealthy VolunteersUnited States
-
National Cancer Institute (NCI)NRG OncologyCompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Clear Cell AdenocarcinomaUnited States
-
Samsung Medical CenterCompletedAdherence, Medication | Percutaneous Coronary Intervention | Compliance, Medication | Platelet Aggregation Inhibitors | Hydroxymethylglutaryl-coa Reductase Inhibitors | Persistence, MedicationKorea, Republic of
-
R-PharmCompletedBreast Cancer | MetastasesUnited States, Netherlands, Argentina, Canada, South Africa, Mexico, Norway, Sweden, France, Germany
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Bone Metastases | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
Icahn School of Medicine at Mount SinaiBristol-Myers SquibbCompletedHepatocellular Carcinoma | Non-small Cell Lung CancerUnited States
-
Bristol-Myers SquibbCompletedDiabetes Mellitus, Non-Insulin-DependentUnited States
-
Bristol-Myers SquibbRecruitingLymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States, France, Netherlands, Australia, United Kingdom, Italy, Spain, Germany
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbWithdrawnResectable Biliary Tract Cancer
-
National Cancer Institute (NCI)TerminatedCervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Carcinoma | Cervical Carcinoma, Non-SquamousTypeUnited States
-
M.D. Anderson Cancer CenterRecruitingMelanoma (Skin)United States
-
The Netherlands Cancer InstituteCompletedHead and Neck Neoplasms | ImmunotherapyNetherlands
-
Bristol-Myers SquibbCompletedMelanomaBelgium, Brazil, United States, Canada, Spain, Greece, France, United Kingdom, Australia, Italy, Austria, Switzerland, Germany, Israel, Russian Federation, Romania, Czechia, Poland, New Zealand
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbTerminatedHealthy Adult VolunteersUnited States
-
Bristol-Myers SquibbWithdrawnStage III or IV Melanoma
-
University of ValenciaCompleted
-
Bristol-Myers SquibbActive, not recruitingPsoriatic ArthritisUnited States, Australia, Belgium, Spain, Argentina, China, Canada, Colombia, Czechia, Germany, Hungary, Italy, Japan, Mexico, Poland, Russian Federation, Taiwan, United Kingdom
-
Bristol-Myers SquibbCompletedRheumatoid ArthritisJapan, Spain, United States, Mexico, Italy, Poland, France, Brazil, Korea, Republic of, Canada, Taiwan, Russian Federation, South Africa, Argentina, Germany, Austria, Netherlands
-
Northwestern UniversityNational Cancer Institute (NCI)Active, not recruiting
-
Bristol-Myers SquibbTerminatedTumorItaly, United States, New Zealand
-
Bristol-Myers SquibbMedarex; Ono Pharma USA IncCompleted
-
Bristol-Myers SquibbCompleted
-
PfizerBristol-Myers SquibbRecruiting
-
Bristol-Myers SquibbRecruitingHeart FailureUnited States, Spain, Canada, Italy, Poland
-
CelgeneRecruitingPrimary Myelofibrosis | Myeloproliferative Disorders | Anemia | Myelofibrosis | Post-Polycythemia Vera MyelofibrosisFrance, Belgium, Spain, Australia, Canada, United States, Korea, Republic of, Romania, Japan, Israel, Italy, Austria, China, Czechia, Germany, Greece, Ireland, Poland, United Kingdom, Hong Kong, Hungary, Lebanon, Argentina, Chile, Colombia and more
-
Bristol-Myers SquibbActive, not recruitingCardiomyopathy, Hypertrophic ObstructiveJapan
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedA Study to Evaluate the Effects on the Single-Dose Drug Levels of Mavacamten in Healthy ParticipantsHealthy ParticipantsUnited States
-
Bristol-Myers SquibbCompletedFollicular Lymphoma | Chronic Lymphocytic Leukemia | Acute Myelogenous Leukemia | Diffuse Large B-Cell LeukemiaUnited States
-
Bristol-Myers SquibbCompletedMultiple MyelomaUnited States
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedHepatitis CUnited States, Australia, Canada, France, Puerto Rico
-
Bristol-Myers SquibbCompletedType 2 DiabetesRussian Federation
-
Bristol-Myers SquibbTerminatedCarcinoma, HepatocellularChina, Korea, Republic of, Taiwan, Singapore